Companies

PDS Biotechnology Corp

PDSB · CIK 0001472091 · operating

$0.68+0.33%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$37.87M
P/E
Fwd P/E-1.03
PEG
P/S
P/B3.49
EV/EBITDA-0.80
EV/Rev

Profitability

Gross Margin
Op. Margin
Net Margin
ROE-41.84%
ROA-17.53%
FCF Margin

Financial Health

Current Ratio2.64
Debt/Equity1.39
Free Cash Flow-$35.06M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth25.90%
Beta1.17
52W High$1.915
52W Low$0.601

About PDS Biotechnology Corp

PDS Biotechnology Corp (PDSB) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $39 million, PDS Biotechnology Corp is a micro-cap company. The stock currently trades at $0.68, up 0.33% today, with a 52-week range of $0.60–$2.20.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-1.03$-1.03+25.9%
2023$-1.39$-1.39+2.8%
2022$-1.43$-1.43-116.7%
2021$-0.66$-0.66
2020
2019
2018
2017
2016
2015

Annual Reports (10-K) · 10 filings

Report DateFiledAccession Number
2024-12-312025-03-270001140361-25-010717SEC ↗
2023-12-312024-03-280001140361-24-016265SEC ↗
2022-12-312023-03-280001140361-23-014279SEC ↗
2021-12-312022-03-310001140361-22-012244SEC ↗
2020-12-312021-03-180001140361-21-009142SEC ↗
2019-12-312020-03-270001140361-20-007252SEC ↗
2018-12-312019-02-210001140361-19-003636SEC ↗
2017-12-312018-03-010001140361-18-011218SEC ↗
2016-12-312017-03-020001140361-17-010287SEC ↗
2015-12-312016-03-080001140361-16-056994SEC ↗